Since the early stages of the COVID-19 vaccine rollout in the U.S., vaccine skeptics have used outdated interviews to spread claims that executives are refusing shots developed by their own ...

CLAIM: Video shows that the CEO of BioNTech, Dr. Ugur Sahin, will not take the COVID-19 vaccine that his firm developed with Pfizer. THE FACTS: Social media posts are misrepresenting an interview that ...

When BioNTech agreed to acquire rival messenger RNA company CureVac in a $1.25 billion stock deal earlier this summer, some financial analysts said the buyout amounted to an out-of-court settlement of ...

The CEO of BioNTech, the biotechnology company that worked with Pfizer to develop one of the COVID-19 vaccines, has been fully inoculated against the virus. He received two doses of his firm’s product ...

Pfizer and BioNTech are confident they can have a vaccine against the novel coronavirus ready for regulatory approval by the middle of October or early November, BioNTech CEO and co-founder Ugur Sahin ...

BOSTON — BioNTech CEO Uğur Şahin had been in marathon meetings since he arrived in this city three days earlier, but if his energy had flagged it didn’t show. The clock had not even struck 8 a.m., and ...

The chief executive of Germany's BioNTech SE said the biggest challenge facing it and partner Pfizer Inc now that their COVID-19 vaccine is authorized for use in the United States will be to scale up ...